Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • voisybay voisybay Jul 18, 2012 11:40 AM Flag

    Blue Sky Assessment

    Is $5-$7 pps after a +++ human clinical trial result a "low" estimate. There are several other milestones that could drive the stock to this level first--NASDAQ listing/announcement of approval of the clinical trials/opening of the manufacturing facility/possible take over bid by large pharmaceutical--can't believe that +++ human trial would only raise pps to this level

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • VB,

      These are my estimates:

      Human trial OK: $12.00
      Trial Results: $25.00

      Major partnership for pain gel: $50.00

      Human trial for scaffold and stem cells OK $75.00
      Trial Results: Priceless!

      JMHO

    • Depends on the order of things. FDA nod and another lesser event could bring $4.50. Successful results would deserve more than the $5 - $7, but would it go to $10? Up-listing will help as would progress with the other lines. Revenue kicking in, forgetaboutit! Like some other thread mentioned, 20X from here and more.

 
NVIV
6.80+0.19(+2.87%)Sep 30 4:00 PMEDT